Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma
Clinical trial NCT02249702 · COMPLETED
Trial details
- NCT number
- NCT02249702
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2017-04-30
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.